Analyst Price Targets — NUTX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 2, 2026 12:02 pm | Ben Haynor | Lake Street | $235.00 | $131.24 | TheFly | Nutex Health initiated with a Buy at Lake Street |
| August 26, 2025 12:03 pm | — | Maxim Group | $205.00 | $84.67 | TheFly | Nutex Health price target lowered to $205 from $225 at Maxim |
| September 18, 2024 7:44 am | Anthony Vendetti | Maxim Group | $45.00 | $24.90 | StreetInsider | Maxim Group Starts Nutex Health (NUTX) at Buy |
Latest News for NUTX
Nutex Health is rated Buy, with a DCF-based price target of $199.31, offering 19.8% upside from $166.40. NUTX's revenue surged from $247.6M in FY2023 to $880.0M TTM ended March 31, 2026, driven by effective use of the No Surprises Act's IDR process. Liquidity and leverage metrics have improved, with debt-to-equity falling below 1.0 and the current ratio at 3.1 in the TTM period.
NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Nutex Health, Inc. (NASDAQ: NUTX) breached their fiduciary duties to shareholders.
Nutex Health Inc. (NUTX) Q1 2026 Earnings Call Transcript
HOUSTON, April 30, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), today announced financial results for the three months ended March 31, 2026. Nutex Health is a physician-led, healthcare services and operations company with 27 hospital facilities in 12 states (hospital division), and a primary care-centric, risk-bearing physician network.
NEW YORK, April 29, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Nutex Health, Inc. (NASDAQ: NUTX) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Nutex Health caused the company to misrepresent or fail to disclose that: (i) HaloMD was achieving lucrative arbitration results…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NUTX.
U.S. House Trading
No House trades found for NUTX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.